ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Neumora Therapeutics Inc

Neumora Therapeutics Inc (NMRA)

9.31
-0.34
(-3.52%)
Closed May 24 4:00PM
9.31
0.00
(0.00%)
After Hours: 4:25PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)
Total Assets 544.75M496.2M450.21M
Total Current Assets 525.74M478.28M442.79M
Cash and Equivalents 412.28M374.04M182.93M
Total Non-Current Assets 19.01M19.71M7.43M
Total Liabilities 32.06M27.12M25.67M
Total Current Liabilities 29.12M25.11M24.61M
Total Non-Current Liabilities 2.93M2.01M1.06M
Common Equity 15k16k16k
Retained Earnings -594.7M-703.43M-757.16M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 429.3M426.23M496.2M
Total Current Assets 415.6M387.96M478.28M
Cash and Equivalents 409.25M240.94M374.04M
Total Non-Current Assets -325.22M-446.85M469.08M
Total Liabilities 24.66M29.4M27.12M
Total Current Liabilities 23.28M23.7M25.11M
Total Non-Current Liabilities 1.38M5.7M2.01M
Total Equity -325.22M-446.85M469.08M
Common Equity 14k16k16k
Retained Earnings -336.61M-467.51M-703.43M